These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6370851)

  • 1. Plasma insulin response to oral glucose load in hepatic cirrhosis.
    Jain AK; Agarwal BK; Bajpai HS; Gupta JP
    Indian J Med Res; 1983 Sep; 78():388-94. PubMed ID: 6370851
    [No Abstract]   [Full Text] [Related]  

  • 2. [Plasma insulin and GH during oral glucose load in liver cirrhosis].
    Greco AV; Ghirlanda G; Altomonte L; Manna R; Rebuzzi AG
    Minerva Med; 1976 Jul; 67(35):2266-72. PubMed ID: 951048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma insulin; insulin resistance and glucose intolerance in children with bilharzial hepatic fibrosis.
    Zaki K; Kantoosh M; Hamam MA; Shoheib S; Mikhail N; Nour H; Zaki F
    Hepatogastroenterology; 1980 Dec; 27(6):417-22. PubMed ID: 7009363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral glucose in cirrhotics. Effects on plasma aminoacid patterns and the role of insulin and glucagon.
    Marchesini G; Forlani G; Angiolini A; Zoli M; Scolari MP; Bianchi FB; Pisi E
    Diabete Metab; 1979 Jun; 5(2):135-9. PubMed ID: 478083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Behavior of plasma/insulin, somatropin and NEFA after intravenous administration of tolbutamide in hepatic cirrhosis].
    Greco AV; Ghirlanda G; Rebuzzi A; Altomonte L; Manna R
    Minerva Med; 1976 Nov; 67(54):3525-32. PubMed ID: 995300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Measurement of plasma insulin and growth hormone after oral glucose tolerance test in patients with alcoholic cirrhosis].
    Descos L; M'Bendi S; Sassolas G; Audigier JC; Sidiqian N; Faure A; Bizollon CA
    Arch Fr Mal App Dig; 1974; 63(1):17-24. PubMed ID: 4441222
    [No Abstract]   [Full Text] [Related]  

  • 7. Glucose tolerance, free fatty acid, and serum insulin responses in patients with cirrhosis.
    Berkowitz D
    Am J Dig Dis; 1969 Oct; 14(10):691-9. PubMed ID: 4898689
    [No Abstract]   [Full Text] [Related]  

  • 8. [Dynamic exploration of carbohydrate metabolism in liver cirrhosis. Determination of free fatty acids and insulin in the blood].
    Perreau P; Joubaud F; Cheguillaume J; Boyer J; Vernin H
    Sem Hop; 1972 Mar; 48(14):957-66. PubMed ID: 4339074
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma insulin response to oral glucose in liver cirrhosis.
    Toccafondi R; Palmas S; Maioli M
    Riv Crit Clin Med; 1970; 70(1):110-9. PubMed ID: 5527337
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum glucose, insulin, and growth hormone in chronic hepatic cirrhosis.
    Samaan NA; Stone DB; Eckhardt RD
    Arch Intern Med; 1969 Aug; 124(2):149-52. PubMed ID: 5797073
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies on serum insulin, blood glucose and nonesterified fatty acid following the oral glucose administration to the normal subjects].
    Yoshimoto A; Okano N; Maezawa A; Ominato K; Sato T; Koseki Y; Komine S
    Radioisotopes; 1982 May; 31(5):245-7. PubMed ID: 6753044
    [No Abstract]   [Full Text] [Related]  

  • 12. [Changes in carbohydrate metabolism in hepatic cirrhosis. IV. Resistance to the effect of insulin].
    Santolaria Fernández F; González Garciá C; González Reimers E; Burgos Ojeda A; Jorge Hernández J; Batista López N; Hernández Nieto L; Bueno Gómez J
    Rev Esp Enferm Apar Dig; 1983 Apr; 63(4):349-56. PubMed ID: 6348895
    [No Abstract]   [Full Text] [Related]  

  • 13. [Disturbances of carbohydrate regulation in hepatic lesions].
    Magnenat P
    Helv Med Acta; 1970 Dec; 35(5):354-62. PubMed ID: 5501843
    [No Abstract]   [Full Text] [Related]  

  • 14. Significance of glucose load in oral glucose tolerance tests. Blood glucose, serum insulin, growth hormone and free fatty acids.
    Christensen NJ; Orskov H; Hansen AP
    Acta Med Scand; 1972 Oct; 192(4):337-42. PubMed ID: 5081072
    [No Abstract]   [Full Text] [Related]  

  • 15. [Changes of glycemia, insulinemia (IRI), and non-esterified free fatty acids during dynamic tests in a group of subjects with hepatic cirrhosis. The Rastinon test].
    Zandomeneghi R
    Minerva Med; 1970 Jan; 61(6):185-9. PubMed ID: 5412764
    [No Abstract]   [Full Text] [Related]  

  • 16. [Mathematical model of the decrease in the level of nonesterified fatty acids after glucose in healthy individuals and in cirrhotics].
    Fabian E; Fabian F; Stork A; Kucerová L; Fabianová J
    Sb Lek; 1971 Mar; 73(3):71-5. PubMed ID: 5555650
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diabetes mellitus secondary to liver diseases. A review (author's transl)].
    Guillon J; Charbonnel B
    Diabete Metab; 1975 Sep; 1(3):191-9. PubMed ID: 791727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver disease, insulin antagonism and diabetes mellitus.
    Creutzfeldt W; Frerichs H; Kneer P
    Horm Metab Res; 1974; Suppl 4():135-42. PubMed ID: 4423508
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical investigation on abnormal glucose tolerance in liver cirrhosis.
    Kato K; Kikuchi S; Ito M
    Gastroenterol Jpn; 1976; 11(1):31-7. PubMed ID: 976684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of atropine on the course of oral glucose tolerance test in patients with liver cirrhosis (author's transl)].
    Brodanová M; Andĕl M; Brodan V; Kuhn E; Vondra K
    Cas Lek Cesk; 1978 Jul; 117(29-30):898-900. PubMed ID: 688315
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.